Ramucirumab

Information about Ramucirumab

Ramucirumab uses

Ramucirumab is used in the treatment of non-small cell lung cancer, stomach cancer and cancer of colon and rectum.

How ramucirumab works

Ramucirumab is an anticancer medication. It works by blocking the ‘VEGF receptor 2’ thereby cutting off the blood supply to the cancer cells. This slows the growth of cancer cells and eventually kills them.

Common side effects of ramucirumab

High blood pressure, Diarrhea, Headache, Protein in urine, Nosebleeds, Decreased potassium level in blood, Infection, Hemorrhage, Stomatitis (Inflammation of the mouth), Hair loss, Decreased white blood cell count (neutrophils), Rash, Intestinal obstruction, Arterial thromboembolism (blood clot in artery), Sepsis, Gastrointestinal perforation, Pneumonia, Cellulitis, Skin infection, Urinary tract infection

Available Medicine for Ramucirumab

  • ₹51546 to ₹257532
    Eli Lilly and Company India Pvt Ltd
    2 variant(s)

Content on this page was last updated on 17 November, 2020, by Dr. Varun Gupta (MD Pharmacology)